Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy
Diabetic retinopathy (DR) continues to be the leading cause of preventable vision loss among working-aged adults, marked by immune dysregulation within the retinal microenvironment. Typically, the retina is considered as an immune-privileged organ, where circulating immune cells are restricted from...
Saved in:
Main Authors: | Bowen Zhao (Author), Yin Zhao (Author), Xufang Sun (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
by: Qi Tang, et al.
Published: (2024) -
Glyoxalase System as a Therapeutic Target against Diabetic Retinopathy
by: Gemma Aragonès, et al.
Published: (2020) -
Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy
by: Popescu M, et al.
Published: (2018) -
Biomarkers in Diabetic Retinopathy and the Therapeutic Implications
by: Katarzyna Zorena, et al.
Published: (2013) -
Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies
by: Maria Vähätupa, et al.
Published: (2020)